Form4insider filings, from the source

SEC Form 3 · accession 0001567619-19-002649

ADURO BIOTECH, INC. · ADRO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Celeste Ferber
Officer — SVP, GC and Secretary
Period of report
Jan 28, 2019
Accepted (ET)
Feb 7, 2019 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———2,591D
Common StockF1holding———1,650D
Common StockF2holding———6,563D
Common StockF3holding———3,282D
Common StockF4holding———15,350D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F5$13.89holding————Mar 10, 2026Common Stock40,000—D
Stock Option (Right to Buy)F6$11.15holding————Dec 11, 2026Common Stock2,400—D
Stock Option (Right to Buy)F7$10.75holding————Jun 11, 2027Common Stock8,750—D
Stock Option (Right to Buy)F8$6.10holding————Feb 8, 2028Common Stock30,650—D

Explanation of responses